
Andy Lane
@lane_andy
Physician-scientist treating & studying leukemia; Associate Chief, Division of Hematologic Neoplasia DFCI; Co-Leader DF/Harvard Cancer Center Leukemia Program
ID: 244503484
https://lanelab.dana-farber.org/ 29-01-2011 13:15:18
1,1K Tweet
2,2K Followers
309 Following

Please apply if you are an early career cancer researcher. Outstanding program and opportunity The Mark Foundation for Cancer Research: themarkfoundation.org/emerging-leade…


Last night, past Mark Foundation Emerging Leader Award winners gathered with this year’s recipients (Mara Sherman Lab Daniel Wahl Liron Bar-Peled Kai Kessenbrock and Ansu Satpathy) to celebrate seven years of this transformational program. #MarkSymposium


Great to hear insights from Jay Bradner, M.D. in conversation with Ross Levine, chair of Memorial Sloan Kettering Cancer Center, on how academic & industry researchers can cooperate in translational research and drug discovery. #CancerInnovation #CancerResearch #MarkSymposium


Great afternoon of talks by Dan Nomura, Jeff Rathmell, Jun Wang, and Cathy Wu on reimagining druggability, the impact of obesity on immunotherapy response, antigen presentation inhibitors, & neoantigen discovery. That’s a wrap on #MarkSymposium 2025 – thanks for following along!


Excited to share our exploration Nature Methods into new horizons opening up in the era of low cost sequencing! 🔥 Deeper sequencing at WGS scale for PPM sensitivity of tumor informed MRD 🔥Duplex sequencing at WGS scale for plasma only exploration of ctDNA Check out thread 👇

We examined the present and future of AI and translational cancer research for Cancer Cell - check out superstar Josephine Yates below for more on this perspective! Dana-Farber News





Foley Family advanced leukemia fellowship Dana-Farber, directed by Marlise R. Luskin MD, MSCE is now open for applications: jobcenter.hematology.org/job/14659


Excited to share our paper out today in Cell Press discovering RNA mis-splicing derived neoantigens & their cognate T cell receptors (TCRs) as well as characterization of endogenous neoantigen T cells in leukemia patients. authors.elsevier.com/sd/article/S00…




👉👉👉Delighted to share our major long-term effort ➡️ our new paper just out online in Blood Neoplasia 📣collaboration on HMA+VEN original prospective clinical trials specifically for #BPDCN led by Naveen Pemmaraju, MD & Marina Konopleva & Andy Lane | #BPDCN #endcancer ashpublications.org/bloodneoplasia…



Leukemia-interested heme/onc fellows - consider joining us as an Advanced Leukemia Fellow! Dynamic and diverse faculty! Dana-Farber Andy Lane H. Moses Murdock Shai Shimony Rahul Vedula Chris Reilly Lachelle Dawn Andrew Hantel Luis E. Aguirre, MD jobcenter.hematology.org/job/14659